Regenxbio
RGNX
RGNX
188 hedge funds and large institutions have $896M invested in Regenxbio in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 60 increasing their positions, 53 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 171 → 188 (+17)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3.87% less ownership
Funds ownership: 90.8% → 86.93% (-3.9%)
Holders
188
Holding in Top 10
3
Calls
$2.37M
Puts
$1.36M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$16.7M | |
| 3 | +$10.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.19M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$9.17M |
Top Sellers
| 1 | -$48.5M | |
| 2 | -$12.8M | |
| 3 | -$8.49M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$6.15M |
| 5 |
JPMorgan Chase & Co
New York
|
-$4.57M |